Jeena M. Thevathasan
About Jeena M. Thevathasan
Jeena M. Thevathasan serves as the Associate Director of Clinical Science at Mirati Therapeutics, bringing over a decade of experience in clinical research and operations within the oncology sector. Her background includes significant roles at Novartis, Tocagen Inc., and NYU Langone Health, where she has developed expertise in managing clinical trials and facilitating communication among diverse project stakeholders.
Work at Mirati Therapeutics
Jeena M. Thevathasan currently holds the position of Associate Director, Clinical Science at Mirati Therapeutics, a role she has been in since 2021. In this capacity, she is responsible for overseeing clinical science initiatives and ensuring the successful execution of clinical trials. Her work involves facilitating communication among project teams, internal study teams, third-party vendors, and affiliates to meet client expectations.
Previous Experience in Clinical Research
Prior to her role at Mirati Therapeutics, Jeena M. Thevathasan accumulated extensive experience in clinical research. She worked at Novartis in various capacities, including Clinical Research Scientist and Expert Clinical Manager, focusing on oncology from 2010 to 2015. She also served as Associate Director of Clinical Operations at Tocagen Inc. from 2018 to 2020 and held positions at Allogene Therapeutics and NYU Langone Health, contributing to her expertise in clinical trial management.
Education and Expertise
Jeena M. Thevathasan earned her Bachelor of Science degree in Psychology and Biology from Binghamton University, where she studied from 1997 to 2001. She later obtained a Master of Public Administration in Health Policy and Management from New York University, completing her studies from 2001 to 2004. Her educational background supports her extensive experience in managing clinical trials, particularly in immuno-oncology.
Clinical Trial Management Skills
Jeena M. Thevathasan has demonstrated exceptional organizational skills in managing clinical trials, particularly in the field of immuno-oncology. She has experience with various therapeutic modalities, including small molecules, biologics, viral, and gene therapies. Her ability to negotiate and manage study budgets from start-up to closeout is a key aspect of her professional skill set.